×
The Standard Group Plc is a multi-media organization with investments in media platforms spanning newspaper print operations, television, radio broadcasting, digital and online services. The Standard Group is recognized as a leading multi-media house in Kenya with a key influence in matters of national and international interest.
  • Standard Group Plc HQ Office,
  • The Standard Group Center,Mombasa Road.
  • P.O Box 30080-00100,Nairobi, Kenya.
  • Telephone number: 0203222111, 0719012111
  • Email: [email protected]

Coronavirus: WHO warns pregnant women not to take Moderna vaccine

News
 The World Health Organization has told pregnant women to avoid the Moderna jab unless they are health workers or at high risk. Photo: Courtesy.

Pregnant women are being warned not to take the Moderna vaccine by the World Health Organization (WHO). Experts at the WHO have urged pregnant women to avoid the vaccine unless they are health workers or at high risk, according to new recommendations. WHO officials also propose the Moderna jab should be administered in two doses at an interval of 28 days, following a review of vaccine data. This interval can be extended to 42 days under exceptional circumstances in a country hard hit by coronavirus, the experts added. The WHO said it does not recommend halving the dose of the Moderna vaccine and also recommended it only be administered in a setting where an allergic reaction can be treated.

READ ALSO: Coronavirus vaccine will not stop people from getting ill and dying, scientists warn

The Moderna vaccine may be less effective against South African variant. The pharma giant is looking to develop a booster shot to increase its effectiveness against the mutant form of the virus. Moderna announced the result of tests saying its vaccine offers protection against all mutations of coronavirus.

READ ALSO: Coronavirus vaccines won't be affected by mutation of the virus

Lab tests found that vaccination with its jab produced no significant impact on antibodies against the UK variant. However there was a six-fold reduction in neutralising antibodies produced against the South African variant.

 

Related Topics


.

Popular this week

.

Latest Articles